Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin, +12

The Lancet Neurology

Advanced ParkinsonContinuous Intrajejunal InfusionNeurologyLevodopa-carbidopa Intestinal GelMedicine +1

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser, +15

Movement Disorders

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

Stuart Montgomery, Krai Chatamra, L. Pauer, +2

The British Journal of Psychiatry

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Dag Nyholm, Per Odin, Anders Johansson, +4

The AAPS Journal

PharmacologyClinical PharmacologyPharmacotherapyNeurologyLevodopa-carbidopa Intestinal Gel +2

Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients

John T. Slevin, Hubert H. Fernandez, Cindy Zadikoff, +5

Journal of Parkinson s Disease

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials

Anthony E. Lang, Ramon L. Rodriguez, James T. Boyd, +18

Movement Disorders

Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

Hubert H. Fernandez, Arvydas Vanagunas, Per Odin, +8

Parkinsonism & Related Disorders

Neurodegenerative DiseasesAdvanced ParkinsonMedicineParkinson DiseaseNeuropharmacology +5

Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

Hubert H. Fernandez, James T. Boyd, Victor S.C. Fung, +13

Movement Disorders

<scp>E</scp>ffect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced <scp>P</scp>arkinson's disease patients

Angelo Antonini, Victor S.C. Fung, James T. Boyd, +5

Movement Disorders

Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease

David G. Standaert, Ramon L. Rodriguez, John T. Slevin, +8

Movement Disorders Clinical Practice